DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

First radiology center opens in Zimbabwe capital to help curb shortage Currently 115 radiologists in country of 14 million people

Onkos Surgical and Insight Medical partner to bring augmented reality to tumor surgery Could this become the new standard of care?

Veritas closes $1 billion GE Healthcare software unit buy Will run newly acquired business as a stand-alone company

Praxair in deal to sell European assets to Taiyo Nippon Sanso Move is dependent on the successful closing of the Praxair-Linde merger

Precision X-Ray and Faxitron Bioptics combine business assets Forming a new global leader in biological irradiation

DaVita hit with $383.5 million jury verdict in dialysis death suit Three patients suffered cardiac arrest after getting GranuFlo therapy

Ultrasound Versus IR: Making decisions about real-time location systems Doing your homework is key to making the right investment in RTLS

Alliance completes deal for Piramal Imaging Expanding market presence in molecular imaging

GE CEO for Latin America arrested in Brazil Part of alleged healthcare racket during his time with Philips Medical Systems

GE's wild ride: key takeaways from Harvard Business Review report Warning against the limits of an M&A business strategy

Demonstration of Accurate's
anti-reflux microcatheters

Guerbet to buy Accurate Medical Therapeutics for over €19.5 million

by Lauren Dubinsky , Senior Reporter
Guerbet announced on Monday that it acquired Accurate Medical Therapeutics for an initial payment of EUR 19.5 million.

Additional payments will be made over the next few years depending on the achievement of regulatory and commercial milestones. The total amount will not surpass EUR 57 million.

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



Accurate has developed a portfolio of microcatheters for image-guided embolization procedures to treat tumors and vascular aneurysms. The products are currently being registered with the U.S. and European health authorities.

"This new range of microcatheters will allow us to help interventional radiology teams deliver a higher quality of care during image-guided embolization procedures," Yves L’Epine, CEO of the Guerbet, told HCB News.

The portfolio comprises two types of microcatheters. One was designed to improve intra-arterial navigation for interventional radiologists, even in the case of lesions that are difficult to access.

The other has the same navigation capabilities, as well as an anti-reflux technology. Side holes were placed in the terminal part of the catheter to create a fluid barrier that prevents the reflux of embolization microspheres.

That technology allows the interventional radiologist to deliver embolization microspheres to the targeted treatment area, while stopping them from refluxing upstream to arteries that irrigate healthy tissues.

Guerbet, which specializes in contrast agents and solutions for medical imaging, purchased Accurate to deepen its stake in the interventional radiology market and "round out its current portfolio," according to L'Epine.

"We want to leverage our expertise in interventional imaging built around the unique position of Lipiodol, standard of care for transarterial chemoembolization of liver cancers," he added.

The arterial embolization for tumors and aneurysms segment of the interventional radiology market is worth about EUR 600 million, according to Guerbet. The microcatheter portion of this segment accounts for EUR 120 million, and is growing at an annual rate of 5 to 10 percent.

The company is expected to start generating sales from this deal by the end of this year and be accretive from the fourth quarter of 2019.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED